Kidney, liver & lung: new FDA approvals
Brand, generic name, approval date and the use the FDA approved it for. No recommendations. Updated 2026-10-12.
Weight loss & diabetesCancerBrain & mental healthInfections & vaccinesHeart & bloodImmune & inflammatoryKidney, liver & lungEyeWomen's & hormonal healthPain & anesthesiaDiagnostic & imaging agentsRare & geneticOther
TrutaknaKidney, liver & lung
atacicept-vymj · Vera Therapeutics Inc..To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progressionLynavoyKidney, liver & lung
linerixibat · InterceptTo treat cholestatic pruritus associated with primary biliary cholangitisVoyxactKidney, liver & lung
sibeprenlimab-szsi · Otsuka Pharm Co LtdTo reduce proteinuria in primary immunoglobulin A nephropathy in adults at risk for disease progressionJascaydKidney, liver & lung
nerandomilast · Boehringer IngelheimTo treat idiopathic pulmonary fibrosisBrinsupriKidney, liver & lung
brensocatib · Insmed Inc.To treat non-cystic fibrosis bronchiectasisVanrafiaKidney, liver & lung
atrasentan · NovartisTo reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progressionAlyftrekKidney, liver & lung
vanzacaftor, tezacaftor, and deutivacaftor · Vertex Pharms Inc.For the treatment of cystic fibrosis (CF) in patients 6 years of age and olderLivdelziKidney, liver & lung
seladelpar · Gilead Sciences Inc.To treat primary biliary cholangitis (PBC)IqirvoKidney, liver & lung
elafibranor · IpsenTo treat primary biliary cholangitis in combination with ursodeoxycholic acidRezdiffraKidney, liver & lung
resmetirom · MadrigalTo treat noncirrhotic non-alcoholic steatohepatitis with moderate to advanced liver scarring